RANDI HAGEN: Open Payments
NPI 1760126221 · MIAMISBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,646 in 88 payments from 18 companies in 2025. Trend: 2023 $1,029 · 2024 $1,859 · 2025 $1,646
Food & beverage: $1,646
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $340 |
| Lundbeck LLC | 11 | $190 |
| Vanda Pharmaceuticals Inc. | 8 | $156 |
| Teva Pharmaceuticals USA, Inc. | 5 | $107 |
| Otsuka America Pharmaceutical, Inc. | 5 | $105 |
| Axsome Therapeutics, Inc. | 4 | $95 |
| Neurocrine BioSciences, Inc. | 4 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Almatica Pharma LLC | 3 | $70 |
| Collegium Pharmaceutical, Inc. | 4 | $69 |
Products named: VRAYLAR, REXULTI, AUSTEDO XR, Auvelity, HETLIOZ, INGREZZA, CAPLYTA, ABILIFY MAINTENA.
Industry payments across OH — which companies pay providers there.
